| 注册
首页|期刊导航|广东医学|临床研究Clusterin 蛋白表达对卵巢癌预后的影响

临床研究Clusterin 蛋白表达对卵巢癌预后的影响

周娟 王琼娟 付艳霞 陈达红 杨国奋

广东医学2013,Vol.34Issue(11):1673-1676,4.
广东医学2013,Vol.34Issue(11):1673-1676,4.

临床研究Clusterin 蛋白表达对卵巢癌预后的影响

The prognostic significance of Clusterin expression in ovarian cancer

周娟 1王琼娟 2付艳霞 2陈达红 1杨国奋2

作者信息

  • 1. 厦门大学附属第一医院妇科,福建厦门,361003
  • 2. 中山大学附属第一医院妇科,广州,510080
  • 折叠

摘要

Abstract

Objective To evaluate the prognostic value of clusterin expression in ovraian cancer . Methods The clusterin immunohistochemistry (IHC) , clinical data and pathological records of 181 patients, who were diagnosed with ovarian cancer between 1993 and 2004, were analyzed. Results The over - expression of clusterin protein in ovarian cancer tissues was significantly correlated with histological type , histological grade and FIGO stage ; though with no significant correlation with age or PTNM status. The survivals in clusterin low - expression and over - expression patients were (89. 7 ±0. 3) and (70. 3 ±0. 8) months, respectively (P = 0. 056). Conclusion The clusterin in ovarian cancer patients correlates with adverse prognostic factors and plays an important role in progression of disease , providing a novel prognostic predictor.

关键词

卵巢癌/组织芯片/免疫组化/Clusterin/预后

Key words

ovarian cancer/ tissue microarray/ mmunohistochemistry Clusterin / prognosis

引用本文复制引用

周娟,王琼娟,付艳霞,陈达红,杨国奋..临床研究Clusterin 蛋白表达对卵巢癌预后的影响[J].广东医学,2013,34(11):1673-1676,4.

基金项目

国家自然科学基金资助项目(编号:81272855),广东省自然科学基金资助项目(编号:s2012010008810),广东省科技计划项目(编号:2010B060900098) (编号:81272855)

广东医学

OA北大核心CSCDCSTPCD

1001-9448

访问量0
|
下载量0
段落导航相关论文